NeuroAIDS in Indian scenario

Recent Trends in Biotechnology and Microbiology

Volumn , Issue , 2010, Pages 155-167

  Verma, Ashish Swarup ^a   Singh, Anchal ^a   Singh, Udai Pratap ^a   Dwivedi, Premendra Dhar ^b  

^a AMITY UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CURING;

HIV INFECTION; HIV PATIENTS; INDIAN GOVERNMENT; INDIAN SCENARIOS; LIFE EXPECTANCIES; NEUROLOGICAL DISORDERS; QUALITY LIFE;

CONTROLLED DRUG DELIVERY;

EID: 80052765287     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (30)

1. Albright, A.V., Strizki, J., Harouse, J.M., Lavi, E., O'connor, M. & Gonzalez-Scarano, F. (1996). HIV-1 infection of cultured human adult oligo endrocytes. Virology, 217: 211-219.
2. Albright, A.V., Shieh, J.T., O'Connor, M.J. & González-Scarano, F. (2000). Characterization of cultured microglia that can be infected by HIV-1. J Neurovirol, 6: S53-60.
3. Anderson, E., Zink, W., Xiong, H. & Gendelman, H.E. (2002). HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immunecompetent mononuclear phagocytes. J Acquir Immune Defic Syndr, 31: 43-54.
4. Bagasra, O., Lavi, E., Bobroski, L., Khalili, K., Pestaner, J.P., Tawadros, R.& Pomerantz, R.J. (1996). Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS, 10: 573-585.
5. Brack-Werner, R. (1999). Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS, 13: 1-22.
6. Brew, B.J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18: 75-78.
7. Chin-Hong, P.V., Deeks, S.G., Liegler, T., Hagos, E., Krone, M.R., Grant, R.M. & Martin, J.N. (2005). High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection. J Acquir Immune Defic Syndr, 40: 463-471.
8. Dandona, L., Lakshmi, V., Kumar, G.A. & Dandona, R. (2006). Is the HIV burden in India being overestimated? BMC Public Health, 6: 308. doi:10.1186/1471-2458-6- 308.
9. Dandona, L., Lakshmi, V., Sudha, T., Kumar, G.A. & Dandona, R. (2006). A population-based study of human immunodeficiency virus in south India reveals major differences from sentinel surveillance-based estimates. BMC Med, 4: 31. doi: 10.1186/1741-7015-4-31.
10. Douaihy, A., Hilsabeck, R.C., Azzam, P., Jain, A. & Daley, D.C. (2008). Neuropsychiatric aspects of coinfection with HIV and hepatitis C virus. AIDS Read, 18: 425-432.
11. Ensoli, F., Cafaro, A., Fiorelli, V., Vannelli, B., Ensoli, B. & Thiele, C.J. (1995). HIV-1 infection of primary human neuroblasts. Virology, 210: 221-225.
12. González-Scarano, F. & Martín-García, J. (2005) The neuropathogenesis of AIDS. Nat Rev Immunol, 5: 69-81.
13. Ghafouri, M., Amini, S., Khalili, K. & Sawaya, B.E. (2006). HIV-1 associated dementia: symptoms and causes. Retrovirology, 3: 28. doi:10.1186/1742-4690-3-28.
14. Giulian, D., Vaca, K. & Noonan, C.A. (1990). Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science, 250: 1593-1596.
15. Gorry, P.R., Ong, C., Thorpe, J., Bannwarth, S., Thompson, K.A., Gatignol, A., Vesselingh, S.L. & Purcell, D.F. (2003). Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res, 4: 463-473.
16. Gottlieb, M.S., Schroff, R., Schanker, H.M., Weisman, J.D., Fan, P.T., Wolf, R.A. & Saxon, A. (1981). Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med, 305: 1425-1431.
17. Haase, A.T. (1986). Pathogenesis of lentivirus infections. Nature, 322: 130-136.
18. Hult, B., Chana, G., Masliah, E. & Everall, I. (2008). Neurobiology of HIV. Int Rev Psychiatry, 20: 3-13.
19. Ioannidis, J.P., Reichlin, S. & Skolnik, P.R. (1995). Long-term productive human immuno-deficiency virus-1 infection in human infant microglia. Am J Pathol, 147: 1200-1206.
20. Kaul, M., Garden, G.A. & Lipton, S.A. (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature, 410: 988-994.
21. Martín-García, J., Kolson, D.L.& González-Scarano, F. (2002). Chemokine receptors in the brain: their role in HIV infection and pathogenesis. AIDS, 16: 1709-1730.
22. McArthur, J.C., Brew, B.J., Nath, A. (2005). Neurological complications of HIV infection. Lancet Neurol, 4: 543-555.
23. McCarthy, M., He, J. & Wood; C. (1998). HIV-1 strain-associated variability in infection of primary neuroglia. J Neurovirol, 4: 80-89.
24. McCombe, J.A., Noorbakhsh, F., Buchholz, C., Trew, M. & Power, C. (2009). NeuroAIDS: a watershed for mental health and nervous system disorders. J Psychiatry Neurosci, 34: 83-85.
25. Obregón, E., Punzón, C., Fernández-Cruz, E., Fresno, M. & Muñoz-Fernández, M.A. (1999). HIV-1 infection induces differentiation of immature neural cells through autocrine tumor necrosis factor and nitric oxide production. Virology, 261: 193-204.
26. Peluso, R., Haase, A., Stowring, L., Edwards, M. & Ventura, P. (1985). A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology, 147: 231-236.
27. Rihs, T.A., Begley, K., Smith, D.E., Sarangapany, J., Callaghan, A., Kelly, M., Post, J.J. & Gold, J. (2006). Efavirenz and chronic neuropsychiatric symptoms: a crosssectional case control study. HIV Med, 7: 544-548.
28. Takahashi, K., Wesselingh, S.L., Griffin, D.E., McArthur, J.C., Johnson, R.T. & Glass, J.D. (1996). Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol, 39: 705-711.
29. Verma, A.S., Bhatt, S.M., Singh, A. & Dwivedi, P.D. (2008). HIV: An Introduction. In: Chauhan AK, Varma A editor. Text Book on Molecular Biotechnology. Delhi: I.K. International; 853-878.
30. Weiss, J.J. & Gorman, J.M. (2006). Psychiatric behavioral aspects of co-management of hepatitis C virus and HIV. Curr HIV/AIDS Rep, 3: 176-181.